Free Trial
LON:ONC

Oncimmune (ONC) Share Price, News & Analysis

Oncimmune logo

About Oncimmune Stock (LON:ONC)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
1.14
8.01
52-Week Range
N/A
Volume
N/A
Average Volume
589,365 shs
Market Capitalization
£1.29 million
P/E Ratio
0.13
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ONC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oncimmune and its competitors with MarketBeat's FREE daily newsletter.

ONC Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Oncimmune Share Chat (ONC)
See More Headlines

ONC Stock Analysis - Frequently Asked Questions

Oncimmune Holdings plc (LON:ONC) released its quarterly earnings results on Monday, February, 10th. The company reported ($4.72) earnings per share (EPS) for the quarter. Oncimmune had a net margin of 581.63% and a negative trailing twelve-month return on equity of 2,277.74%.

Shares of ONC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oncimmune investors own include B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Greencore Group (GNC), Intel (INTC) and IQE (IQE).

Company Calendar

Last Earnings
2/10/2025
Today
7/20/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:ONC
CIK
N/A
Fax
N/A
Employees
52
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 8.87
Trailing P/E Ratio
0.13
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£10.79 million
Net Margins
581.63%
Pretax Margin
N/A
Return on Equity
-2,277.74%
Return on Assets
-26.38%

Debt

Debt-to-Equity Ratio
-412.06
Current Ratio
1.14
Quick Ratio
0.63

Sales & Book Value

Annual Sales
£1.86 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
11.96
Book Value
GBX (1.72) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
113,304,985
Free Float
N/A
Market Cap
£1.29 million
Optionable
Not Optionable
Beta
1.19
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (LON:ONC) was last updated on 7/21/2025 by MarketBeat.com Staff
From Our Partners